Detalhe da pesquisa
1.
Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation.
Breast Cancer Res;
23(1): 79, 2021 08 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34344426
2.
Gene- and pathway-level analyses of iCOGS variants highlight novel signaling pathways underlying familial breast cancer susceptibility.
Int J Cancer;
148(8): 1895-1909, 2021 04 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33368296
3.
A new hybrid record linkage process to make epidemiological databases interoperable: application to the GEMO and GENEPSO studies involving BRCA1 and BRCA2 mutation carriers.
BMC Med Res Methodol;
21(1): 155, 2021 07 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34325649
4.
Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing.
Int J Cancer;
144(8): 1962-1974, 2019 04 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30303537
5.
Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers.
Breast Cancer Res;
20(1): 28, 2018 04 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29665859
6.
FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor.
Hum Mol Genet;
24(18): 5345-55, 2015 Sep 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26130695
7.
GENESIS: a French national resource to study the missing heritability of breast cancer.
BMC Cancer;
16: 13, 2016 Jan 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26758370
8.
Mutation analysis of PALB2 gene in French breast cancer families.
Breast Cancer Res Treat;
154(3): 463-71, 2015 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26564480
9.
Safety of the Breast Cancer Adjuvant Radiotherapy in Ataxia-Telangiectasia Mutated Variant Carriers.
Cancers (Basel);
16(7)2024 Apr 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38611095
10.
Association and performance of polygenic risk scores for breast cancer among French women presenting or not a familial predisposition to the disease.
Eur J Cancer;
179: 76-86, 2023 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36509001
11.
TUMOSPEC: A Nation-Wide Study of Hereditary Breast and Ovarian Cancer Families with a Predicted Pathogenic Variant Identified through Multigene Panel Testing.
Cancers (Basel);
13(15)2021 Jul 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34359559
12.
The Spectrum of FANCM Protein Truncating Variants in European Breast Cancer Cases.
Cancers (Basel);
12(2)2020 01 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31991861
13.
Processing of a complex multiply damaged DNA site by human cell extracts and purified repair proteins.
Nucleic Acids Res;
33(1): 260-71, 2005.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15647508
14.
Mutation screening of MIR146A/B and BRCA1/2 3'-UTRs in the GENESIS study.
Eur J Hum Genet;
24(9): 1324-9, 2016 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26785832
15.
Targeted Sequencing of the Mitochondrial Genome of Women at High Risk of Breast Cancer without Detectable Mutations in BRCA1/2.
PLoS One;
10(9): e0136192, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26406445